2017 first half results presentation

Operating revenues, growth data, profitability and the behavior of our products.


No votes yet
 
Related
Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) has announced the purchase of Falithrom®, which was owned by Hexal AG (“Hexal”), a company...
1 min
09/01/2019
0 min
06/11/2018